DNTH
$72.09-3.27%
Dianthus Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.010%US Stock Market 0.007%Russell 3000 0.006%
Dianthus Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Dianthus Therapeutics Inc. total returns by year (2019–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $41.21 | $72.09 | 0.0% | +74.9% | |
| 2025 | $21.80 | $41.21 | 0.0% | +89.0% | |
| 2024 | $10.40 | $21.80 | 0.0% | +109.6% | |
| 2023 | $6.40 | $10.40 | 0.0% | +62.5% | |
| 2022 | $70.88 | $6.40 | 0.0% | -91.0% | |
| 2021 | $125.44 | $70.88 | 0.0% | -43.5% | |
| 2020 | $242.56 | $125.44 | 0.0% | -48.3% | |
| 2019 | $91.20 | $242.56 | 0.0% | +166.0% |
- Annualized
- -12.4%
- 2019–2026
- Average year
- +34.9%
- 7 full years
- Best year
- +166.0%
- 2019
- Worst year
- -91.0%
- 2022
- Positive years
- 4/7
- 57% up
Annualized (CAGR)
-12.4%
2019–2026
Average year
+34.9%
7 full years
Best year
+166.0%
2019
Worst year
-91.0%
2022
Positive years
4/7
57% up
Total return by period#
Annual
-150%-100%-50%0%50%100%150%
2019+166%'19
2020-48%'20
2021-43%'21
2022-91%'22
2023+63%'23
2024+110%'24
2025+89%'25
2026+75%'26
Methodology#
Total returns, dividends reinvested, measured on DNTH. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Dianthus Therapeutics Inc.'s average annual return?
- Since 2019, Dianthus Therapeutics Inc. (DNTH) has returned about -12.4% a year (the compound annual growth rate) and an average calendar-year return of 34.9%.
- What were Dianthus Therapeutics Inc.'s best and worst years?
- Over 2019–2026, the best year was 2019 (+166.0%) and the worst was 2022 (-91.0%).
- How often is Dianthus Therapeutics Inc. up in a year?
- 4 of the 7 full years since 2019 were positive — about 57% of the time.
More on Dianthus Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100